Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 58

Sort by

Sort Order Select

Journal Articles

Navigating the nexus of MRD and novel agents in ALL

Anjali S. Advani, Edward A. Copelan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 9–16.

https://doi.org/10.1182/hematology.2019000008

Published: 2019

Journal Articles

Pediatric-inspired protocols in adult acute lymphoblastic leukemia: are the results bearing fruit?

Lori Muffly, Emily Curran

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 17–23.

https://doi.org/10.1182/hematology.2019000009

Published: 2019

Journal Articles

Moving immunotherapy into the front line in ALL

Amanda Winters, Lia Gore

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 209–217.

https://doi.org/10.1182/hematology.2019000017

Published: 2019

Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.

https://doi.org/10.1182/asheducation-2018.1.9

Published: 2018

Journal Articles

Genetics and prognosis of ALL in children vs adults

Kathryn G. Roberts

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 137–145.

https://doi.org/10.1182/asheducation-2018.1.137

Published: 2018

Journal Articles

Cytotoxic therapy in acute myeloid leukemia: not quite dead yet

Laura C. Michaelis

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 51–62.

https://doi.org/10.1182/asheducation-2018.1.51

Published: 2018

Journal Articles

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

Monika Brüggemann, Michaela Kotrova

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 13–21.

https://doi.org/10.1182/asheducation-2017.1.13

Published: 2017

Journal Articles

Current management of Philadelphia chromosome positive ALL and the role of stem cell transplantation

Farhad Ravandi

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 22–27.

https://doi.org/10.1182/asheducation-2017.1.22

Published: 2017

Journal Articles

Progress in adult ALL: incorporation of new agents to frontline treatment

Jessica Leonard, Wendy Stock

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 28–36.

https://doi.org/10.1182/asheducation-2017.1.28

Published: 2017

Journal Articles

Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment)

Rachael Hough, Ajay Vora

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 251–258.

https://doi.org/10.1182/asheducation-2017.1.251

Published: 2017

Journal Articles

Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemia

Lewis B. Silverman

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 259–264.

https://doi.org/10.1182/asheducation-2017.1.259

Published: 2017

Journal Articles

Ph-like acute lymphoblastic leukemia

Thai Hoa Tran, Mignon L. Loh

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 561–566.

https://doi.org/10.1182/asheducation-2016.1.561

Published: 2016

Journal Articles

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Noelle V. Frey, David L. Porter

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 567–572.

https://doi.org/10.1182/asheducation-2016.1.567

Published: 2016

Journal Articles

Treatment of older patients with acute lymphoblastic leukemia

Nicola Gökbuget

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 573–579.

https://doi.org/10.1182/asheducation-2016.1.573

Published: 2016

Journal Articles

The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia

Daniel J. DeAngelo

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 400–405.

https://doi.org/10.1182/asheducation-2015.1.400

Published: 2015

Journal Articles

Management of adult Ph-positive acute lymphoblastic leukemia

Sabina Chiaretti, Robin Foà

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 406–413.

https://doi.org/10.1182/asheducation-2015.1.406

Published: 2015

Journal Articles

Chimeric antigen receptor T-cell therapy for ALL

Shannon L. Maude, Elizabeth J. Shpall, Stephan A. Grupp

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 559–564.

https://doi.org/10.1182/asheducation-2014.1.559

Published: 2014

Journal Articles

The genomic landscape of acute lymphoblastic leukemia in children and young adults

Charles G. Mullighan

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 174–180.

https://doi.org/10.1182/asheducation-2014.1.174

Published: 2014

Journal Articles

Balancing cure and long-term risks in acute lymphoblastic leukemia

Lewis B. Silverman

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 190–197.

https://doi.org/10.1182/asheducation-2014.1.190

Published: 2014

Journal Articles

Detection and management of minimal residual disease in acute lymphoblastic leukemia

Martin Schrappe

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 244–249.

https://doi.org/10.1182/asheducation-2014.1.244

Published: 2014

NARROW

Navigating the nexus of MRD and novel agents in ALL

Pediatric-inspired protocols in adult acute lymphoblastic leukemia: are the results bearing fruit?

Moving immunotherapy into the front line in ALL

Antibody-based therapies in patients with acute lymphoblastic leukemia

Genetics and prognosis of ALL in children vs adults

Cytotoxic therapy in acute myeloid leukemia: not quite dead yet

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

Current management of Philadelphia chromosome positive ALL and the role of stem cell transplantation

Progress in adult ALL: incorporation of new agents to frontline treatment

Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment)

Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemia

Ph-like acute lymphoblastic leukemia

Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia

Treatment of older patients with acute lymphoblastic leukemia

The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia

Management of adult Ph-positive acute lymphoblastic leukemia

Chimeric antigen receptor T-cell therapy for ALL

The genomic landscape of acute lymphoblastic leukemia in children and young adults

Balancing cure and long-term risks in acute lymphoblastic leukemia

Detection and management of minimal residual disease in acute lymphoblastic leukemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only